Form 8-K - Current report:
SEC Accession No. 0001102624-09-000504
Filing Date
2009-11-04
Accepted
2009-11-04 10:34:59
Documents
2
Period of Report
2009-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 IMMUCELL CORPORATION 8-K immucell8k.htm 8-K 4966
2 IMMUCELL CORPORATION PRESS RELEASE immucellcorporation.htm EX-99 6457
  Complete submission text file 0001102624-09-000504.txt   12925
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 091156584
SIC: 2835 In Vitro & In Vivo Diagnostic Substances